Cargando…

A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer

Cervical cancer (CC) is one of the most common malignant tumors of the female reproductive system. And the immune system disorder in patients results in an increasing incidence rate and mortality rate. Pyroptosis is an immune system-related programmed cell death pathway that produces systemic inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Haoran, Yang, Meiqin, Dong, Wei, Yin, Bo, Ding, Jianyi, Huang, Baoyou, Zheng, Qingliang, Li, Fang, Han, Lingfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099437/
https://www.ncbi.nlm.nih.gov/pubmed/35574296
http://dx.doi.org/10.3389/fonc.2022.873725
_version_ 1784706605398360064
author Hu, Haoran
Yang, Meiqin
Dong, Wei
Yin, Bo
Ding, Jianyi
Huang, Baoyou
Zheng, Qingliang
Li, Fang
Han, Lingfei
author_facet Hu, Haoran
Yang, Meiqin
Dong, Wei
Yin, Bo
Ding, Jianyi
Huang, Baoyou
Zheng, Qingliang
Li, Fang
Han, Lingfei
author_sort Hu, Haoran
collection PubMed
description Cervical cancer (CC) is one of the most common malignant tumors of the female reproductive system. And the immune system disorder in patients results in an increasing incidence rate and mortality rate. Pyroptosis is an immune system-related programmed cell death pathway that produces systemic inflammation by releasing pro-inflammatory intracellular components. However, the diagnostic significance of pyroptosis-related genes (PRGs) in CC is still unclear. Therefore, we identified 52 PRGs from the TCGA database and screened three Differentially Expressed Pyroptosis-Related Genes (DEPRGs) in the prognosis of cervical cancer: CHMP4C, GZMB, TNF. The least absolute shrinkage and selection operator (LASSO) regression analysis and multivariate COX regression analysis were then used to construct a gene panel based on the three prognostic DEPRGs. The patients were divided into high-and low-risk groups based on the median risk score of the panel. According to the Kaplan-Meier curve, there was a substantial difference in survival rates between the two groups, with the high-risk group’s survival rate being significantly lower than the low-risk group’s. The PCA and t-SNE analyses revealed that the panel was able to differentiate patients into high-and low-risk groups. The area under the ROC curve (AUC) shows that the prognostic panel has high sensitivity and specificity. The risk score could then be employed as an independent prognostic factor using univariate and multivariate COX regression analyses paired with clinical data. The analyses of GO and KEGG functional enrichment of differentially expressed genes (DEGs) in the high-and low-risk groups revealed that these genes were primarily engaged in immune response and inflammatory cell chemotaxis. To illustrate immune cell infiltration in CC patients further, we used ssGSEA to compare immune-related cells and immune pathway activation between the high-and low-risk groups. The link between three prognostic DEPRGs and immune-related cells was still being discussed after evaluating immune cell infiltration in the TCGA cohort with “CIBERSORT.” In addition, the GEPIA database and qRT-PCR analysis were used to verify the expression levels of prognostic DEPRGs. In conclusion, PRGs are critical in tumor immunity and can be utilized to predict the prognosis of CC.
format Online
Article
Text
id pubmed-9099437
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90994372022-05-14 A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer Hu, Haoran Yang, Meiqin Dong, Wei Yin, Bo Ding, Jianyi Huang, Baoyou Zheng, Qingliang Li, Fang Han, Lingfei Front Oncol Oncology Cervical cancer (CC) is one of the most common malignant tumors of the female reproductive system. And the immune system disorder in patients results in an increasing incidence rate and mortality rate. Pyroptosis is an immune system-related programmed cell death pathway that produces systemic inflammation by releasing pro-inflammatory intracellular components. However, the diagnostic significance of pyroptosis-related genes (PRGs) in CC is still unclear. Therefore, we identified 52 PRGs from the TCGA database and screened three Differentially Expressed Pyroptosis-Related Genes (DEPRGs) in the prognosis of cervical cancer: CHMP4C, GZMB, TNF. The least absolute shrinkage and selection operator (LASSO) regression analysis and multivariate COX regression analysis were then used to construct a gene panel based on the three prognostic DEPRGs. The patients were divided into high-and low-risk groups based on the median risk score of the panel. According to the Kaplan-Meier curve, there was a substantial difference in survival rates between the two groups, with the high-risk group’s survival rate being significantly lower than the low-risk group’s. The PCA and t-SNE analyses revealed that the panel was able to differentiate patients into high-and low-risk groups. The area under the ROC curve (AUC) shows that the prognostic panel has high sensitivity and specificity. The risk score could then be employed as an independent prognostic factor using univariate and multivariate COX regression analyses paired with clinical data. The analyses of GO and KEGG functional enrichment of differentially expressed genes (DEGs) in the high-and low-risk groups revealed that these genes were primarily engaged in immune response and inflammatory cell chemotaxis. To illustrate immune cell infiltration in CC patients further, we used ssGSEA to compare immune-related cells and immune pathway activation between the high-and low-risk groups. The link between three prognostic DEPRGs and immune-related cells was still being discussed after evaluating immune cell infiltration in the TCGA cohort with “CIBERSORT.” In addition, the GEPIA database and qRT-PCR analysis were used to verify the expression levels of prognostic DEPRGs. In conclusion, PRGs are critical in tumor immunity and can be utilized to predict the prognosis of CC. Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9099437/ /pubmed/35574296 http://dx.doi.org/10.3389/fonc.2022.873725 Text en Copyright © 2022 Hu, Yang, Dong, Yin, Ding, Huang, Zheng, Li and Han https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Hu, Haoran
Yang, Meiqin
Dong, Wei
Yin, Bo
Ding, Jianyi
Huang, Baoyou
Zheng, Qingliang
Li, Fang
Han, Lingfei
A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer
title A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer
title_full A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer
title_fullStr A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer
title_full_unstemmed A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer
title_short A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer
title_sort pyroptosis-related gene panel for predicting the prognosis and immune microenvironment of cervical cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099437/
https://www.ncbi.nlm.nih.gov/pubmed/35574296
http://dx.doi.org/10.3389/fonc.2022.873725
work_keys_str_mv AT huhaoran apyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT yangmeiqin apyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT dongwei apyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT yinbo apyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT dingjianyi apyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT huangbaoyou apyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT zhengqingliang apyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT lifang apyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT hanlingfei apyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT huhaoran pyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT yangmeiqin pyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT dongwei pyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT yinbo pyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT dingjianyi pyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT huangbaoyou pyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT zhengqingliang pyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT lifang pyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer
AT hanlingfei pyroptosisrelatedgenepanelforpredictingtheprognosisandimmunemicroenvironmentofcervicalcancer